Novocure exec chairman on receiving permission to accelerate lung cancer treatment trial

Novocure Executive Chairman Bill Doyle joined Jim Cramer on "Mad Money" to after an independent data monitoring committee concluded its LUNAR trial of Tumor Treating Fields should continue with no evidence of increased systemic toxicity.